Clinical trials: Respiratory Loading

COVID-19

Pharmacokinetics, Pharmacodynamics, and Safety of Single-dose Sotrovimab in High-risk Pediatric Participants With Mild to Moderate COVID-19

• Terminated
• Age: 0 days to 18 years
• Phase 2
• Results posted

This Phase 2b study will evaluate the pharmacokinetics (PK), pharmacodynamics (PD) and safety of sotrovimab in pediatric participants from birth to less than (<)18 years old with mild-to-moderate Coronavirus Disease-2019…

Trial name

COMET-PACE (NCT05124210)

Testing

Sotrovimab

Where

2 sites in United States

Volunteers

8 people

Sponsor

GlaxoSmithKline